Skip to main content
FinSpry Logo
FinSpry
BVS logo
BVS
(NASDAQ)
Bioventus Inc.
$8.97-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Bioventus (BVS) Stock Price & Financial Analysis

Bioventus Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.73 - $9.05
52-Week High$9.56
52-Week Low$5.81
Open$9.05
Volume318.38K
Average Volume (3M)318.38K
Market Cap618.17M
Shares Outstanding68.91M
P/E Ratio (TTM)27.74
Price to Sales (P/S)1.11
Price to Book (P/B)3.43
EV/EBITDA8.44
Revenue (TTM)568.09M
Net Income (TTM)22.73M
Free Cash Flow (TTM)72.11M
EPS (TTM)$0.33
Profit Margin4.00%
Operating Margin10.17%
Return on Equity (ROE)12.35%
Debt to Equity1.69
50-Day MA$8.56
200-Day MA$7.45
52-Week Change-2.35%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Bioventus

What is the current stock price for BVS?

As of the latest trading session, BVS stock trades at $8.97. The 52-week range is $5.81–$9.56, with a day range of $8.73–$9.05.

What is the P/E ratio for BVS?

Bioventus's trailing P/E ratio is 27.7, meaning investors pay $27.7 for every $1 of annual earnings. Bioventus operates in the Healthcare sector.

Does BVS pay dividends?

Bioventus does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BVS?

Based on 2 analysts, the consensus for BVS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BVS?

Bioventus's market capitalization is $618.2M, classifying it as a small-cap company. Bioventus operates in the Healthcare sector within the Medical Devices industry.